Interviews

The following interviews reflect expertise at the cutting edge of aging: Nir Barzilai, who has convinced the FDA to completely change how it categorizes indications to trial the diabetes drug metformin for its ability to delay aging, the main risk factor for many chronic diseases; Paul Dagum, a pioneer who uses digital biomarkers to help diagnose and manage mental health conditions, which are on the rise as a result of the pandemic; Thomas Balkizas, who combines his Big Tech experience working with Amazon Web Services with the ability to sniff out the next disruptors on the horizon and his perspective as an investor who founded Alpha Tech Capital; Teemu Sanu, founder of Nightingale Health, which uses blood-based molecular data and AI to predict disease risk, aiming to abolish chronic diseases through prevention; and Nicola Palmarini, who was formerly with the behemoth IBM as its head of ethics and aging, and is now director of the National Innovation for Ageing in the UK...